Anti-streptococcal antibodies in Chinese patients with type -1 narcolepsy.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Narcolepsy type 1 (NT1) is considered to be an autoimmune disease, and streptococcal infection may be an environmental trigger. However, previous studies from Asian narcolepsy patients did not reveal elevated anti-streptolysin O [ASO]. The aim is to investigate whether large sample Chinese patients with NT1 have an increase in antistreptococcal antibody titers.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Sleep Med

Title: Sleep medicine

Publisher: Elsevier BV

ISSN (Electronic): 1878-5506

ISSN (Print): 1389-9457

Publication date (Electronic): August 2020

Volume: 72

Affiliations

[1 ] Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China.

[2 ] Department of Respiratory and Critical Care Medicine, Peking University People's Hospital, Beijing, 100044, China. Electronic address: hanfang1@hotmail.com.

Article

Publisher Item ID: S1389-9457(20)30138-6

DOI: 10.1016/j.sleep.2020.03.019

PubMed ID: 32540635

SO-VID: b2b1bd95-1bf3-45f1-ba9e-add1ef056453

History

Keywords: Cataplexy,Streptococcus,Narcolepsy

Data availability:

Keywords: Cataplexy, Streptococcus, Narcolepsy

Comments

Comment on this article

scite_

Cited by 8

See all cited by

Anti-streptococcal antibodies in Chinese patients with type -1 narcolepsy.

Read this article at